Evaluation of Postoperative Outcomes and Mortality in Laparoscopic and Robotic Distal Pancreatectomy

NCT07338409 | Completed

• 1 other identifier: 2025/109
• Study Type: observational
• Target: 126
• Locations: 1 country
• Sites: 1

Brief Summary

Minimally invasive distal pancreatectomy can be performed using either a laparoscopic or robotic approach. These minimally invasive techniques are becoming increasingly common in the surgical treatment of both benign and malignant pancreatic lesions. They offer several advantages over traditional open surgery, such as less postoperative pain, better cosmetic results, faster recovery, less blood loss during surgery, and lower healthcare costs. However, despite these advantages, evidence comparing postoperative outcomes, particularly complications, between laparoscopic and robotic distal pancreatectomy remains limited. Previous studies suggest that robotic surgery may offer technical benefits, such as greater accuracy and precision, which could potentially result in fewer complications. However, the available literature is diverse and often based on small cohorts.

Conditions

Distal Pancreatectomy (DP)

Outcome Measures

Primary Outcomes (1)

• 90-day postoperative complications

  Postoperative in-hospital complications in the 90-day postoperative period

  90- days postoperative

Secondary Outcomes (7)

• Cumulative postoperative morbidity

  Patients that underwent distal pancreatectomy surgery at Jessa Hospital from 01/01/2020 up until 30/06/2025

• Length of hospital stay

  Time between start of surgery and discharge of hospital

• Re-admissions

  within 30 days of discharge

• Conversion rate

  Time from surgery until last follow up of the study

• Mortality

  Until the end of the study (31/12/2025)

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All patients that underwent distal pancreatectomy surgery at Jessa Hospital from 01/01/2020 up until 31/12/2024 were included in the study.

You may qualify if:

• Underwent distal pancreatectomy surgery at Jessa Hospital from 01/01/2020 up until 31/12/2024.

You may not qualify if:

• Underwent open procedure
• Restpancreatectomy
• Central pancreatectomy

Sponsors & Collaborators

• Jessa Hospital: lead

Study Sites (1)

Jessa Hospital

Hasselt, 3500, Belgium

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr, PhD

Study Record Dates

• First Submitted: December 16, 2025
• First Posted: January 13, 2026
• Study Start: March 4, 2025
• Primary Completion: June 5, 2025
• Study Completion: June 5, 2025
• Last Updated: January 13, 2026

Record last verified: 2026-01

Data Sharing

• IPD Sharing: Will not share

Locations

BE (1)